MedTech Business Academy
Attention MedTech executives: Are you looking to grow exponentially and remain competitive in the MedTech Industry? Our renowned professors, the MedTeXperts, have launched a new podcast, the "Medtech Business Academy," where you can earn your MEDTECH MBA! We will be sharing our insights related to ...
Recent Episodes
114
Oct. 15, 2026
The New MedTech Sales Playbook: Selling Into Value-Based Care | Ep. 114
Healthcare is moving deeper into value-based care, and MedTech companies will need to change how they sell. As payment models evolve, the person buying a technology may not be the person who ultimately benefits from it. In this episode of the MedTech Business Academy, Scott Alexander and Barbara Strain break down what the shift toward value-based care means for MedTech manufacturers. They discuss why cost and value often sit in different departments, why selling only to the department using the
113
Aug. 27, 2026
Provider Margins vs. Medtech Reality | Ep. 113
Hospitals are posting record 5%+ operating margins, yet medtech commercial teams are facing radio silence, longer sales cycles, and tighter budgets. Hospital rejections aren't about a lack of innovation—they reflect a sharp disconnect between hospital financial priorities and traditional sales pitches. In this episode of the Medtech Business Academy, Barbara Strain, Scott Alexander, and Skender Daerti break down the modern hospital margin paradox. They discuss how health systems are systematica
112
Aug. 13, 2026
New Trends in Value Analysis | Ep. 112
Value Analysis Committees strike fear into medtech commercial teams, but hospital rejections are rarely about product quality. Instead, they reflect a flawed commercial strategy. In this episode of the Medtech Business Academy, Barbara Strain, Scott Alexander, and Tom Hickey break down modern hospital purchasing. They discuss the rise of triad leadership structures, the shift toward operational nurse leads, and why pitching only physicians guarantees a stalled committee review. The panel expla
111
July 30, 2026
How the 14% Win at Trade Shows | Ep. 111
Trade shows are expensive, time-consuming, and frequently disappointing. Yet medtech companies continue attending them because exhibiting is treated as a cost of doing business rather than an investment that must produce a measurable return. In this episode of the Medtech Business Academy, Skender Daerti, Barbara Strain, and Mike Sperduti examine why 86% of companies rate their conference ROI as poor or fair and what the successful 14% do differently. They discuss how shrinking provider travel
110
July 16, 2026
What Winning Medtech Companies Do Differently | Ep 110
In this episode of the Medtech Business Academy, Mike Sperduti is joined by Skender Daerti, Tom Hickey, and Scott Alexander for a conversation about what winning medtech companies are doing differently in today’s market. The group breaks down why the old medtech sales playbook is no longer enough. Physician employment, value analysis, longer sales cycles, tighter budgets, and workflow pressure have changed how hospitals evaluate new technology. A strong clinical claim still matters, but success
109
June 18, 2026
Education Is the Moat with Guest Eric Poirier | Ep. 109
Education is often treated as something that happens after a medtech product is sold. In this episode of the Medtech Business Academy, Eric Poirier, CEO of Atmosphere Apps, joins Scott Alexander, Barbara Strain, and Skender Daerti to explain why education should be viewed as a core part of adoption, customer satisfaction, and long-term account protection. The conversation centers on a simple but important idea: education can become a moat. When clinicians, sales teams, educators, and hospital s